PURPOSE: This study evaluates retrospectively those patients diagnosed with adolescent and young adult bone tumors whose applied to our clinic between 1989-1999.
RATIONALE AND METHOD: Between 1989-1999, 50 patients, aged between 15-30, with bone tumors diagnosis applied to our clinic. 37 were male and 13 were female (Men/Women: 2.8) 20 patients had osteosarcoma (40%), 13 had Ewing‘s sarcoma (26%), 5 had hasta fibrous histiocytoma malignant (10%). The most frequent tumor localization was the lower extremity (25 patients, 50%). 9 patients were at stage 4b (18%), 14 were at stage 4a (28%), 22 patients were at stage 2b (44%) and 5 patients were at stage lb (10%). Lung metastasis was the most frequent one. 38 patients (76%) received systemic chemotherapy and 32 patients (64%) received radiotherapy. The average survival period was 18 months ( Range 2-66 months).
RESULTS: The factor effecting survival was found as a localization of metastdsis.
AMAÇ: Bu çalışmada 1989-1999 tarihleri arasında kliniğimize müracaat eden adölesan ve genç erişkin genç erişkin dönemi kemik tümörü tamlı hastalar retrospektif olarak değerlendirilmiştir.
GEREÇ VE YÖNTEM: 1989-1999 tarihleri arasında 15-30 yaş arası kemik tümörü tanılı 50 hasta kliniğimize müracaat etmiştir. Erkek hasta 37, kadın hasta 13 idi.( Erkek / Kadın: 2.8). 20 hasta osteosarkom (%40), 13 hasta Ewing sarkomu (%26), 5 hasta malign fibröz histiositom‘dur (%10). Tümörün en sık yerleşim yeri; 25 hasta (%50) ile alt ekstremdedir. 9 hasta stage 4b (%18), 14 hasta stage 4a (%28), 22 hasta stage 2b (%44), 5 hasta stage lb dir. En sık akciğer metastazı görülmüştür. Hastaların 38‘ine (%76) sistemik kemoterapi, 32‘sine (%64) radyoterapi uygulanmıştır. Ortalama sağ kalım süresi 18 aydır (2-66 ay).
SONUÇ: Sağ kalım üzerine en etkili faktör olarak; uzak metastazın lokalizasyonu bulunmuştur.